- If You're Looking for a V-Bottom, This May Not Be the Market for You
- It Was a Good Day Trading
- Monday's After-Hours Movers
- Monday's Closing Stats
- Market Rallies as Fed's Tariff Rate Cut Statement Turns Heads
- This Week in Charts
- Bitcoin Can Reach New Heights as Trump, BRICS Reset World Order
- Selling the Rips, Buying the Dips
- Recommended Reading (on Cannabis)
- Things I Did Today
- Gold and Oil Have Followed Very Different Paths. But Here's What Could Be Next.
- New Price Target for AMD as Apple, Nvidia See Tariff Boost
- More MSOS
- As Tariffs Torment Investors, Not All Is Gloomy on Wall Street
- A Fast Gain on Apple
- Session Lows for Many Sectors
- Covered Index Shorts for Nice Gain
- Market Conditions Remain Poor, But I'm Targeting These 3 Stocks
- Ludacris? No, But...
- Ludacris? No, But...
- Midday Market Stats and Charts
- More Index Shorts
- VIDEO: Why We Scooped Up Shares of Multiple Holdings
- Palantir Price Target Upside After Blockbuster NATO, DOGE Partnerships
- Learning From the Great Financial Crisis as Trump Shocks System
- Programming Note
- Short to the Core(Weave)
- More Index Shorts
- Keith on Currency
- Apple Short
- Tweet of the Day (Part 4)
- We're Buying Shares of These 6 Holdings Ahead of Sector-Specific Tariffs
- Some Sell Side Comments on My Positions
- Charting the Premarket Movers
- Upside, Downside Market Movers in the Morning
- ETF Action in the A.M.
- Fed Speakers Today
- Baby Steps
- Tweet of the Day Part (Trois)
- Surprise, Surprise: Musk/Trump Bromance Erodes, Tesla Slumps, DOGE Fails ...
- More Premarket Trades
- 3 Key Issues Are Presenting Substantial Headwinds for U.S. Stocks
- 'Newsy' and Unpredictable
- Exemption Redemption?
- Tweet of the Day (Part Deux)
- All Is Good...Remain Calm!
- Charting the Technicals
- Back Shorting KO
- Marks and Dalio on a Potential Paradigm Shift
- We're Planning Some Moves as Trump Delivers Tech Tariff Exemptions
- Tweet of the Day
- Picture of the Day
- One Common Theme
- More Tariff Talk
- Tariff Talk
- Seasonal Cycles for April Have Been Wrong
- The Market Is Less, But Still Oversold
- Premarket Trading
- An Old Biotech Friend Is Back in My Portfolio